Predictive value of major depressive episodes and demographic characteristics for past-year marijuana use among 12 to 17-year-olds in the US - A retrospective, cross-sectional design

Main Article Content

Tamaraemumoemi Emmanuella Okoro

Keywords

Major Depressive Episodes, Marijuana Use, Sociodemographic Variables, Adolescents

Abstract

Background: The decriminalization of cannabis in multiple states within the United States and the increasing societal approval of its non-medical consumption has notable implications for public health, particularly among the youth population. This study aimed to examine the relationship between previous major depressive episodes (MDE) and sociodemographic factors with marijuana consumption in the past year among adolescents in the United States.
Methodology: Retrospective, cross-sectional design utilizing data from the 2021 US NSDUH report. The sample consisted of 10,315 adolescents aged 12-17. The primary outcome measure was past-year daily/near-daily marijuana use (≥300 days). Chi-square test explored relationships between exposure variables and marijuana use. Logistic regression identified predictors of marijuana use. Level of significance was p<0.05.
Results: About half were male (51.6%), middle schoolers (54.3%), and White (50.5%). Prevalence of marijuana use and MDE was 10.4% and 19.9%, respectively. Independent associations for marijuana use include MDE (adjusted OR = 2.05; CI: 1.54-2.73; p < 0.001), increasing age (adjusted OR = 3.19 – 6.52; p = 0.001), high school education (adjusted OR=1.70; 95% CI: 1.14-2.53; p = 0.010), worsening general health (adjusted OR = 1.58 – 2.11; p < 0.001) and income levels greater than two times below the poverty threshold (aOR = 2.30; 95% CI: 1.22 - 4.32; p=0.011).
Conclusion: The findings from this study are fundamental for health promotion efforts and intervention programs to reduce the occurrence of depression and marijuana use in adolescents. However, although the findings of the study may be generalized to the US population, the primary outcome measure of ≥300-day past-year daily/near-daily marijuana use may exclude occasional users with heavy cannabis consumption on a less frequent basis who are also at risk of developing adverse cannabis effects, including cognitive deficits and cannabis use disorder.

Abstract 10 | PDF Downloads 0

References

1. Hammond CJ, Chaney A, Hendrickson B, Sharma P. Cannabis use among U.S. adolescents in the era of marijuana legalization: a review of changing use patterns, comorbidity, and health correlates. Int Rev Psychiatry. 2020 May;32(3):221-234.
2. Sheehan BE, Grucza RA, Plunk AD. Association of Racial Disparity of Cannabis Possession Arrests Among Adults and Youths With Statewide Cannabis Decriminalization and Legalization. JAMA Health Forum. 2021 Oct 29;2(10):e213435.
3. Yu B, Chen X, Chen X, Yan H. Marijuana legalization and historical trends in marijuana use among US residents aged 12-25: results from the 1979-2016 National Survey on drug use and health. BMC Public Health. 2020 Feb 4;20(1):156.
4. SAMHSA (2022). Key substance use and mental health indicators in the United States: Results from the 2021 National Survey on Drug Use and Health (HHS Publication No. PEP22-07-01-005, NSDUH Series H-57). Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration. Accessed August 2023 https://www.samhsa.gov/data/report/2021-nsduh-annual-national-report
5. Sultan RS, Zhang AW, Olfson M, Kwizera MH, Levin FR. Non-disordered Cannabis Use Among US Adolescents. JAMA Netw Open. 2023 May 1;6(5):e2311294.6.
6. Fischer B, Russell C, Sabioni P, van den Brink W, Le Foll B, Hall W, Rehm J, Room R. Lower-Risk Cannabis Use Guidelines: A Comprehensive Update of Evidence and Recommendations. Am J Public Health. 2017 Aug;107(8):e1-e12.
7. Kerr WC, Williams E, Patterson D, Karriker-Jaffe KJ, Greenfield TK. Extending the Harm to Others Paradigm: Comparing Marijuana- and Alcohol-Attributed Harms in Washington State. J Psychoactive Drugs. 2021 Apr-Jun;53(2):149-157.
8. Daly M. Prevalence of Depression Among Adolescents in the U.S. From 2009 to 2019: Analysis of Trends by Sex, Race/Ethnicity, and Income. J Adolesc Health. 2022 Mar;70(3):496-499.
9. Gukasyan N, Strain EC. Relationship between cannabis use frequency and major depressive disorder in adolescents: Findings from the National Survey on Drug Use and Health 2012-2017. Drug Alcohol Depend. 2020 Mar 1; 208:107867.
10. Troup LJ, Andrzejewski JA, Braunwalder JT, Torrence RD. The relationship between cannabis use and measures of anxiety and depression in a sample of college campus cannabis users and non-users post-state legalization in Colorado. Peer J. 2016 Dec 8;4:e2782.10.
11. Gilder DA, Ehlers CL. Depression symptoms associated with cannabis dependence in an adolescent American Indian community sample. Am J Addict. 2012 Nov-Dec; 21(6):536-43.
12. Leadbeater BJ, Ames ME, Linden-Carmichael AN. Age-varying effects of cannabis use frequency and disorder on symptoms of psychosis, depression, and anxiety in adolescents and adults. Addiction. 2019 Feb;114(2):278-293.
13. Womack SR, Shaw DS, Weaver CM, Forbes EE. Bidirectional Associations Between Cannabis Use and Depressive Symptoms from Adolescence Through Early Adulthood Among At-Risk Young Men. J Stud Alcohol Drugs. 2016 Mar;77(2):287-97.
14. Wilson S, Dumornay NM. Rising Rates of Adolescent Depression in the United States: Challenges and Opportunities in the 2020s. J Adolesc Health. 2022 Mar;70(3):354-355.
15. Andrabi N, Khoddam R, Leventhal AM. Socioeconomic disparities in adolescent substance use: Role of enjoyable alternative substance-free activities. Soc Sci Med. 2017 Mar;176:175-182.
16. Churchill V, Chubb CS, Popova L, Spears CA, Pigott T. The association between cannabis and depression: an updated Systematic Review and Meta-analysis. Psychol Med. 2025 Feb 12;55:e44.
17. Schaefer JD, Hamdi NR, Malone SM, Iacono WG. Associations between adolescent cannabis use and young-adult functioning in three longitudinal twin studies. PNAS. 2021, March; 118 (14)
18. U.S. Census Bureau, 2020. National Demographic Analysis Tables: 2020. Accessed August 2023. https://www.census.gov/data/tables/2020/demo/popest/2020-demographic-analysis-tables.html
19. Jeffers AM, Glantz S, Byers A, Keyhani S. Sociodemographic Characteristics Associated with and Prevalence and Frequency of Cannabis Use Among Adults in the US. JAMA Netw Open. 2021 Nov;4(11):e2136571.
20. Boehnke KF, Scott JR, Litinas E, Sisley S, Williams DA, Clauw DJ. High-Frequency Medical Cannabis Use Is Associated With Worse Pain Among Individuals with Chronic Pain. The Journal of Pain. 2020 Sept; 21(5–6) 570-581.
21. Caulkins, JP. Changes in self-reported cannabis use in the United States from 1979 to 2022. Addiction. 2024 May, 119(9), 1648-1652.
22. Asante KO, Atorkey P. Cannabis and amphetamine use among school-going adolescents in sub-Saharan Africa: a multi-country analysis of prevalence and associated factors. BMC Psychiatry. 2023 Oct 24;23(1):778.
23. Hinckley JD, Mikulich-Gilbertson SK, He JP, Bhatia D, Ellingson JM, Nguyenkhoa Vu B, et al. Cannabis Use Is Associated With Depression Severity and Suicidality in the National Comorbidity Survey-Adolescent Supplement. JAACAP Open. 2023 Jun;1(1):24-35.
24. Cerdá M, Bordelois PM, Keyes KM, Galea S, Koenen KC, Pardini D. Cumulative and recent psychiatric symptoms as predictors of substance use onset: does timing matter? Addiction. 2013 Dec;108(12):2119-28.
25. Demidenko MI, Huntley ED, Du L, Estor C, Si Y, Wagner C, Clarke P, Keating DP. Individual and Community Level Developmental Adversities: Associations with Marijuana and Alcohol Use in Late-Adolescents and Young Adults. J Youth Adolesc. 2024 Apr;53(4):799-813.
26. Patrick ME, Peterson SJ, Terry-McElrath YM, Rogan SEB, Solberg MA. Trends in coping reasons for marijuana use among U.S. adolescents from 2016 to 2022. Addict Behav. 2024 Jan; 148:107845.
27. Patrick ME, Parks MJ, Fairlie AM, Kreski NT, Keyes KM, Miech R. Using Substances to Cope With the COVID-19 Pandemic: U.S. National Data at Age 19 Years. J Adolesc Health. 2022 Feb;70(2):340-344.
28. Nguyen, N. N. (2021). The Significance of School-based Programs, School-based Activities, and Community-Based Activities Against Marijuana Use Among Adolescents. Journal of Drug Issues, 51(4), 711-721.
29. Twenge JM, Martin GN. Gender differences in associations between digital media use and psychological well-being: Evidence from three large datasets. J Adolesc. 2020 Feb; 79:91-102.
30. Amitay G. Experiences of gender-responsive trauma-informed care among female youth in deep-end residential group care facilities. Children and Youth Services Review. 2023, 155 (107285).
31. Ladegard, K & Bhatia, D. Impact of Cannabis Legalization on Adolescent Cannabis Use. Psychiatr Clin. 2023 Dec; 46 (4): 635–646
32. Tucker JS, Rodriguez A, Pedersen ER, Seelam R, Shih RA, & D’Amico EJ (2019). Greater risk for frequent marijuana use and problems among young adult marijuana users with a medical marijuana card. Drug and Alcohol Dependence, 194, 178–183.
33. Mattingly DT, Richardson MK, Hart JL. Prevalence of and trends in current cannabis use among US youth and adults, 2013-2022. Drug Alcohol Depend Rep. 2024 Jun 28; 12:100253.
34. Odom GC, Cottler LB, Striley CW, Lopez-Quintero C. Perceived Risk of Weekly Cannabis Use, Past 30-Day Cannabis Use, and Frequency of Cannabis Use Among Pregnant Women in the United States. Int J Womens Health. 2020 Nov 16; 12:1075-1088.
35. Buckner JD, Shah SM, Dean KE, Zvolensky MJ. Cannabis use frequency and use-related impairment among African-American and White users: the impact of cannabis use motives. Ethn Health. 2016 Aug;21(3):318-31.
36. Montgomery L, Dixon S, Mantey DS. Racial and Ethnic Differences in Cannabis Use and Cannabis Use Disorder: Implications for Researchers. Curr Addict Rep. 2022 Mar;9(1):14-22.
37. Wang Q, Wang H. Cannabis and tobacco use among adolescents aged 12-17 years from 16 low- and middle-income countries. J Glob Health 2023; 13:04066.
38. Odeigah OW, Dumbili EW, Nelson EU. Cannabis use patterns, prevalence, and risk factors in Nigeria: a systematic review and meta-analysis. J Cannabis Res. 2025 Nov 11;7(1): 88.